A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

Home News Business Stocks Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins ...

When drugmaker Civica Inc. completed its manufacturing plant in Petersburg in 2022, the company projected it would have insulin on the shelves of drugstores by 2024. But 2024 has come and gone ...

Novo said last year it would pull its Levemir insulin from the U.S. market at the end of 2024, months after cutting its price by 65% to $108 a vial and $162 for a 5-pack of injector pens.

Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply.

9. Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024. Novo Nordisk. Press release; March 14, 2023.

Now one week into the month, Utahns with diabetes are desperate to find insulin. "When I've tried to order it, it's always, 'We don't have it in stock' or 'It's on backorder,'" said Shayne Oleen.

Eli Lilly also said that all of its other insulin products — including Humalog and Insulin Lispro injection in prefilled pens — are still available across the U.S. "We recognize that any supply ...

In the meantime, all other Lilly insulin products – including Humalog and Insulin Lispro Injection in prefilled pens (KwikPen®) – are currently available in the U.S.

The 10 mL vials of Humalog and Insulin Lispro Injection will not be in stock for wholesalers starting in April. The company states that they are still manufacturing these products and will begin ...

Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of Humalog® and Insulin Lispro Injection are or will be temporarily out of ...